Key Impact Metrics
- 125% improvement in supplier oversight and compliance coverage
- 55% reduction in internal resource bandwidth requirements
- 40% reduction in operational costs
Overview
Empowering Aesthetic Practices with Advanced Solutions
- Country: United States
- Market Segment: Medical Aesthetics – Dermatology Devices
- Device Type: Professional Skin Treatment Devices
- Engagement Scope: Quality Assurance & Regulatory Affairs (QARA), Supplier Qualification, Post-Market Compliance
The client is a U.S.-based medical aesthetics company recognized as a top-tier innovator in professional dermatology and skin health solutions. The company focuses on delivering minimally invasive, clinically impactful technologies that empower aesthetic practitioners to achieve visible improvements in skin rejuvenation and restoration.
With a growing global demand for minimally invasive aesthetic procedures, the client sought to rapidly expand its presence in international markets.
Challenges
Scaling for Rapid Global Market Expansion
As the client expanded rapidly in global markets, it required robust regulatory and quality operations for timely and compliant multi-country market entry.
Regulatory Ambiguity in Global Markets
Navigating differing regional regulatory pathways introduced uncertainty, particularly in distinguishing between medical device and pharmaceutical frameworks. This lack of clarity could potentially impact submission strategies and delay approvals.
Limited Internal Regulatory Bandwidth
The client faced constraints in internal regulatory resources, making it difficult to manage growing volumes of submissions, documentation, and compliance activities for multiple geographies.
Fragmented Supplier Quality and Traceability
A complex supplier ecosystem led to inconsistencies in quality control, documentation, and traceability. This created challenges in maintaining supplier compliance and audit readiness.
Inefficient Complaint Handling and CAPA Execution
High volumes of product complaints, coupled with unstructured processes, resulted in delays in investigation, root cause analysis, and implementation of corrective and preventive actions (CAPA).
Gaps in Post-Market Surveillance (PMS)
The absence of a structured PMS strategy limited visibility into product performance trends, impacting proactive risk management and continuous improvement efforts.
Our Solution
SJML brings strong regulatory expertise in multiple MedTech domains, including medical devices, in vitro diagnostics, medical aesthetics, cosmeceuticals, and Software as a Medical Device (SaMD). With experience serving over 80 international markets, our in-house QARA experts adopted a structured and proactive approach to help the client achieve timely market access. Furthermore, SJML aligned the client’s innovation to uphold stringent product quality standards, improving compliance and promoting sustained global growth.
Supplier Qualification and Audit Management
SJML conducted detailed supplier qualification audits as per ISO 13485 requirements. We reviewed the client’s Quality Management Systems (QMS), process controls, quality records, and CAPA effectiveness. Remote audits were executed to verify compliance with regulatory and contractual requirements, while accelerating closure of audit non-conformities to strengthen supplier oversight.
DHF and DMR Remediation
Existing Device History Files (DHFs) were reviewed for completeness, traceability, and compliance. SJML created and remediated DHFs and Device Master Records (DMRs) in conformance with ISO 13485 and FDA 21 CFR Part 820, establishing readiness for design transfer and regulatory submissions.
Documentation Structuring for Global Expansion
SJML performed gap assessments against global regulatory requirements, including EU MDR and FDA frameworks, to identify missing or incomplete documentation. A centralized documentation system was set up to facilitate structured updates, improved traceability, and enhanced audit readiness across markets.
Risk Management and Compliance Alignment
Comprehensive risk management practices were implemented through development and updating of FMEA and risk management files. All activities were structured according to ISO 14971 requirements to allow for systematic risk identification, evaluation, and mitigation.
International Regulatory Execution
SJML supported end-to-end regulatory submissions by updating technical dossiers, preparing and submitting applications, and managing regulatory queries. Continuous coordination led to timely approvals for target markets.
Product Complaint Management and CAPA
A comprehensive complaint lifecycle management framework was brought in place, covering intake, triaging, evaluation, investigation, and closure. Root cause analysis (RCA) and CAPA processes were implemented, with cross-functional coordination to accelerate resolution and ensure compliance with SOPs and regulatory requirements. Trend tracking drove continuous process improvement.
Outcomes
Faster Market Entry and Improved Regulatory Efficiency
Enhanced Supplier Oversight
SJML strengthened supplier qualification and audit processes, achieving a 125% improvement in supplier oversight and compliance coverage. This resulted in better control over supplier quality, improved documentation practices, and enhanced overall audit readiness.
Improvement in Operational Efficiency
By taking ownership of regulatory, quality, and post-market activities, SJML delivered ~55% bandwidth savings for the client’s internal teams. Consequently, the client was able to redeploy internal resources toward core innovation and strategic business expansion initiatives.
Reduced Costs
Streamlined regulatory workflows, centralized documentation, and optimized processes led to ~40% reduction in operational costs.
Accelerated Regulatory Execution
Structured documentation, proactive regulatory solutions, and efficient query management enabled faster and more streamlined multi-country submissions for timely market access.
Improved Post-Market Compliance
Implementation of a structured complaint management framework improved investigation timelines, strengthened CAPA effectiveness, and contributed to more proactive post-market surveillance.
A Robust Compliance Foundation for Global Expansion
SJML’s partnership helped the client streamline regulatory execution while strengthening overall quality systems. By establishing a resilient compliance ecosystem, SJML enabled faster market access, improved audit readiness, and supported sustained growth in global markets.
